IMVT — Immunovant, Inc. stock price, charts and financials

QT87Immunovant, Inc.

Immunovant, Inc. (NASDAQ: IMVT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
39.36
+0.85+2.21%
OverviewShort InterestFilings
IMVTQT87Immunovant, Inc.·NASDAQ
39.36+2.21%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 24, 20264Statement of changes in beneficial ownership
Jul 22, 2026DEF 14ADefinitive proxy statement
Jul 22, 2026ARSAnnual report to shareholders
Jul 22, 2026DEFA14AAdditional proxy soliciting materials
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
May 29, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 20, 20264Statement of changes in beneficial ownership
May 20, 202610-KAnnual report
May 20, 20268-KCurrent report
May 01, 20264Statement of changes in beneficial ownership
Apr 24, 20264Statement of changes in beneficial ownership
Apr 24, 20264Statement of changes in beneficial ownership
#1 / 25 of 388
Page
▼
/ 16